World Journal of Hepatology - Baishideng Publishing Group

Advanced Search

BPG is committed to discovery and dissemination of knowledge

JOURNAL HOME

Number of total visits: 1518437

Number of visits today: 223

Number of downloads: 541123

MEMBERSHIP

BPG JOURNALS

Open-Access Journal

Other Issues: Previous | Next | Latest | Archive | Issue 4 (1442)

Contents Volume 6 Issue 4 April 27, 2014

Editorial

Drug-induced autoimmune liver disease: A diagnostic dilemma of an increasingly reported disease

Agustin Castiella, Eva Zapata, M Isabel Lucena, Raúl J Andrade

World J Hepatol 6(4):160-168. Published online Apr 27, 2014. doi: 10.4254/wjh.v6.i4.160

Review

Lipid lowering effects of iodothyronines: In vivo and in vitro studies on rat liver

Laura Vergani

World J Hepatol 6(4):169-177. Published online Apr 27, 2014. doi: 10.4254/wjh.v6.i4.169

Update on inflammatory bowel disease in patients with primary sclerosing cholangitis

Christos Tsaitas, Anysia Semertzidou, Emmanouil Sinakos

World J Hepatol 6(4):178-187. Published online Apr 27, 2014. doi: 10.4254/wjh.v6.i4.178

Effects of resveratrol in experimental and clinical non-alcoholic fatty liver disease

Sara Heebøll, Karen Louise Thomsen, Steen B Pedersen, Hendrik Vilstrup, Jacob George, Henning Grønbæk

World J Hepatol 6(4):188-198. Published online Apr 27, 2014. doi: 10.4254/wjh.v6.i4.188

Insulin sensitizers for the treatment of non-alcoholic fatty liver disease

Zeynel Abidin Ozturk, Abdurrahman Kadayifci

World J Hepatol 6(4):199-206. Published online Apr 27, 2014. doi: 10.4254/wjh.v6.i4.199

Mechanisms of fibrogenesis in liver cirrhosis: The molecular aspects of epithelial-mesenchymal transition

Sun-Jae Lee, Kyung-Hyun Kim, Kwan-Kyu Park

World J Hepatol 6(4):207-216. Published online Apr 27, 2014. doi: 10.4254/wjh.v6.i4.207

Minireviews

Pediatric non-alcoholic fatty liver disease: New insights and future directions

Pierluigi Marzuillo, Emanuele Miraglia del Giudice, Nicola Santoro

World J Hepatol 6(4):217-225. Published online Apr 27, 2014. doi: 10.4254/wjh.v6.i4.217

To treat or not to treat the "immunotolerant phase" of hepatitis B infection: A tunnel of controversy

Mohamed A Mekky

World J Hepatol 6(4):226-229. Published online Apr 27, 2014. doi: 10.4254/wjh.v6.i4.226

Original Article

Melatonin attenuates cisplatin-induced HepG2 cell death via the regulation of mTOR and ERCC1 expressions

Kangsadarn Bennukul, Sucha Numkliang, Vijittra Leardkamolkarn

World J Hepatol 6(4):230-242. Published online Apr 27, 2014. doi: 10.4254/wjh.v6.i4.230

Brief Article

Murine model to study brain, behavior and immunity during hepatic encephalopathy

Lindisley Ferreira Gomides, Pedro Elias Marques, Bruno Engler Faleiros, Rafaela Vaz Pereira, Sylvia Stella Amaral, Thais Reis Lage, Gustavo Henrique Souza Resende, Patricia Alves Maia Guidine, Giselle Foureaux, Fabíola Mara Ribeiro, Fabiana Paiva Martins, Marco Antônio Peliky Fontes, Anderson José Ferreira, Remo Castro Russo, Mauro Martins Teixeira, Márcio Flávio Moraes, Antonio Lúcio Teixeira, Gustavo Batista Menezes

World J Hepatol 6(4):243-250. Published online Apr 27, 2014. doi: 10.4254/wjh.v6.i4.243

Clinical Practice

Nuclear medicine dynamic investigations in the diagnosis of Budd-Chiari syndrome

Mircea Dragoteanu, Ioan-Adrian Balea, Cecilia-Diana Piglesan

World J Hepatol 6(4):251-262. Published online Apr 27, 2014. doi: 10.4254/wjh.v6.i4.251